Petlife Pharmaceuticals, Inc. (PTLF) financial statements (2021 and earlier)

Company profile

Business Address 10120 SO. EASTERN AVENUE,
HENDERSON,, NV 89052
State of Incorp. NV
Fiscal Year End August 31
SIC 286 - Industrial Organic Chemicals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

2/28/2018
Q2
11/30/2017
Q1
8/31/2017
Q4
5/31/2017
Q3
2/28/2017
Q2
11/30/2016
Q1
8/31/2016
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8545400291
Cash and cash equivalents8545400291
Inventory, net of allowances, customer advances and progress billings  1818   
Inventory  1818   
Prepaid expense 31 213  
Other undisclosed current assets  (18)    
Total current assets:8585518213291
Noncurrent Assets
Intangible assets, net (including goodwill)   252   
Intangible assets, net (excluding goodwill)   252   
Total noncurrent assets:   252   
TOTAL ASSETS:85855270213291
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:529512531415350514292
Accounts payable295290307336370  
Accrued liabilities234222224794  
Other undisclosed accounts payable and accrued liabilities    (24)514292
Debt2782973123171010 
Derivative instruments and hedges, liabilities585448102    
Due to related parties1010101030915010
Other undisclosed current liabilities5795634818504573,5002,934
Total current liabilities:1,9811,8301,4361,5921,1264,1743,236
Noncurrent Liabilities
Total liabilities:1,9811,8301,4361,5921,1264,1743,236
Stockholders' equity
Stockholders' equity attributable to parent(1,973)(1,772)(1,381)(1,322)(912)(4,145)(3,235)
Preferred stock333    
Common stock8074747062448
Additional paid in capital29,22529,00528,93026,99726,59922,0583,888
Accumulated deficit(31,282)(30,855)(30,388)(28,389)(27,574)(26,247)(7,131)
Total stockholders' equity:(1,973)(1,772)(1,381)(1,322)(912)(4,145)(3,235)
TOTAL LIABILITIES AND EQUITY:85855270213291

Income statement (P&L) ($ in thousands)

2/28/2018
Q2
11/30/2017
Q1
8/31/2017
Q4
5/31/2017
Q3
2/28/2017
Q2
11/30/2016
Q1
8/31/2016
Q4
Operating expenses(143)(118)(1,037)(143)(42)(19,113)(3,322)
Other undisclosed operating loss(40)(76)(678)(429)(1,213)  
Operating loss:(183)(193)(1,715)(572)(1,255)(19,113)(3,322)
Interest and debt expense(114)(87)(577)(4)(12)(2) 
Net loss:(297)(280)(2,292)(576)(1,267)(19,116)(3,322)
Other undisclosed net income (loss) attributable to parent(130)(186)293(239)(50)  
Net loss available to common stockholders, diluted:(427)(467)(1,999)(815)(1,317)(19,116)(3,322)

Comprehensive Income ($ in thousands)

2/28/2018
Q2
11/30/2017
Q1
8/31/2017
Q4
5/31/2017
Q3
2/28/2017
Q2
11/30/2016
Q1
8/31/2016
Q4
Net loss:(297)(280)(2,292)(576)(1,267)(19,116)(3,322)
Comprehensive loss, net of tax, attributable to parent:(297)(280)(2,292)(576)(1,267)(19,116)(3,322)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: